Clinical Trials Directory

Trials / Completed

CompletedNCT01416584

A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
98 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effectiveness of the Therapeutic Workplace in promoting methadone treatment and increasing abstinence in unemployed, out-of-treatment injection heroine users.

Detailed description

A randomized study is planned for 5 years to evaluate the effectiveness of the Therapeutic Workplace in promoting methadone treatment and abstinence in unemployed injection drug users. Participants will be recruited through street outreach, at agencies that serve the target populations, and informal word-of-mouth referrals. Participants will be invited to attend the workplace and to enroll in the methadone treatment. To engage participants in the workplace, they will be allowed to work independent of whether they enroll in methadone treatment and independent of their drug use. The workplace participants (N=162) will be randomly assigned to three groups. The "Usual Care Control" participants will be allowed to work independent of their methadone use or urinalysis results. The "Methadone Contingency" participants will be required to take methadone to attend work, and will receive a brief pay decrease for failing to take their medication. The "Methadone \& Abstinence Contingency" participants will be required to take their medication in order to attend work, as well as receive a brief pay decrease for any positive urine samples for both cocaine and methadone.

Conditions

Interventions

TypeNameDescription
BEHAVIORALmethadone contingencyParticipants had to enroll in methadone treatment and take daily doses of methadone to gain access to the workplace.
BEHAVIORALMethadone & Abstinence ContingencyParticipants had to enroll in methadone treatment and take daily doses of methadone to gain access to the workplace and they had to provide opiate and cocaine negative urine samples to maintain the maximum pay.

Timeline

Start date
2008-10-01
Primary completion
2013-10-01
Completion
2014-04-01
First posted
2011-08-15
Last updated
2017-12-05
Results posted
2017-09-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01416584. Inclusion in this directory is not an endorsement.